J C Bundren — Endo Lab

rct 2000

Depressive mood symptoms associated with ovarian suppression

Fertility and sterility ·doi:10.1016/s0015-0282(00)01607-1

OBJECTIVE: To determine if sertraline is helpful in the management of depressive symptoms associated with ovarian suppression during GnRH agonist therapy as compared with a placebo-controlled group. DESIGN: Double-blind placebo-controlled …

review 1998

Depressive symptoms associated with gonadotropin-releasing hormone agonists

Depression and anxiety ·doi:10.1002/(sici)1520-6394(1998)7:4<171::aid-da5>3.0.co;2-d

The gonadotropin-releasing hormone (GnRH) agonists are a relatively new class of drugs that are potentially effective in treating disorders that are aggravated either by estrogen or testosterone. GnRH agonists are effective in the treatment…

nonrandomized-trial 1998

Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy

Biological psychiatry ·doi:10.1016/s0006-3223(97)00396-x

BACKGROUND: Endometriosis is thought to affect 5-10% of reproductive age women in the general population and is commonly treated with gonadotropin-releasing hormone (GnRH) agonists. Recent studies suggest depressive symptoms are associated …

case-report 1997

Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy

Psychopharmacology bulletin

Gonadotropin-releasing hormone (GnRH) agonists are synthetic derivatives of the native decapeptide produced by the hypothalamus. These agents cause a reversible suppression of the synthesis and release of luteinizing hormone (LH) and follic…